# ![@zohmbastic Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2273512572.png) @zohmbastic zohm

No specific company named "zohm" appears in the provided tweets. However, various companies are trending with updates on earnings, analyst upgrades and downgrades, and new partnerships. Some companies like $MARa, $FIVE, and $RLX reported strong quarterly earnings.

### Engagements: [------] [#](/creator/twitter::2273512572/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:interactions.svg)

- [--] Week [-------] -10%
- [--] Month [---------] +31%
- [--] Months [----------] +145%
- [--] Year [----------] +180%

### Mentions: [---] [#](/creator/twitter::2273512572/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:posts_active.svg)

- [--] Week [---] -18%
- [--] Month [-----] +35%
- [--] Months [-----] +130%
- [--] Year [-----] +149%

### Followers: [------] [#](/creator/twitter::2273512572/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:followers.svg)

- [--] Week [------] +0.20%
- [--] Month [------] +3.60%
- [--] Months [------] +24%
- [--] Year [------] +53%

### CreatorRank: [-------] [#](/creator/twitter::2273512572/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  #3280 [finance](/list/finance)  16.78% [cryptocurrencies](/list/cryptocurrencies)  #2199 [exchanges](/list/exchanges)  #1103 [technology brands](/list/technology-brands)  3.44% [financial services](/list/financial-services)  #645 [countries](/list/countries)  2.06% [fashion brands](/list/fashion-brands)  0.96% [vc firms](/list/vc-firms)  0.28% [currencies](/list/currencies)  0.28%

**Social topic influence**
[target](/topic/target) #566, [strong](/topic/strong) 4.81%, [nasdaq](/topic/nasdaq) #155, [$ua](/topic/$ua) #6, [in the](/topic/in-the) 2.48%, [morgan stanley](/topic/morgan-stanley) 2.34%, [$uaa](/topic/$uaa) #6, [ai](/topic/ai) 2.2%, [$eras](/topic/$eras) 2.06%, [goldman sachs](/topic/goldman-sachs) #460

**Top accounts mentioned or mentioned by**
[@doepke_michel](/creator/undefined) [@byebyegoodguy](/creator/undefined) [@pnani456](/creator/undefined) [@brenbto](/creator/undefined) [@maximusholla](/creator/undefined) [@monaco_biotech](/creator/undefined) [@sunrgu](/creator/undefined) [@rdglinvestors](/creator/undefined) [@trade_velocity](/creator/undefined) [@hellojintao](/creator/undefined) [@alexgiovannetti](/creator/undefined) [@mwm76](/creator/undefined) [@traderbasha](/creator/undefined) [@erictheumpire](/creator/undefined) [@aktienakademie](/creator/undefined)

**Top assets mentioned**
[Under Armour Inc Class C (UA)](/topic/$ua) [Morgan Stanley (MS)](/topic/morgan-stanley) [Under Armour Inc Class A (UAA)](/topic/$uaa) [Erasca, Inc.  (ERAS)](/topic/$eras) [Goldman Sachs (GS)](/topic/goldman-sachs) [AT&T Inc. (T)](/topic/$t) [Fastly, Inc. (FSLY)](/topic/$fsly) [Alumis Inc. (ALMS)](/topic/$alms) [BioAge Labs, Inc. (BIOA)](/topic/$bioa) [Kenvue Inc. (KVUE)](/topic/$kvue) [Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)](/topic/$teva) [Comcast Corporation (CMCSA)](/topic/$cmcsa) [Arteris, Inc. (AIP)](/topic/$aip) [Olema Pharmaceuticals, Inc. (OLMA)](/topic/$olma) [Beta Finance (BETA)](/topic/$beta) [TeraWulf Inc. (WULF)](/topic/$wulf) [HealthSci.AI (HSAI)](/topic/$hsai) [Cosmos (ATOM)](/topic/$atom) [Verizon Communications Inc. (VZ)](/topic/$vz) [ACV Auctions Inc. (ACVA)](/topic/$acva) [Alignment Healthcare, Inc. (ALHC)](/topic/$alhc) [Devon Energy Corp (DVN)](/topic/$dvn) [Applied Optoelectronics, Inc. (AAOI)](/topic/$aaoi) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern) [Corsair Gaming, Inc. (CRSR)](/topic/$crsr) [Warby Parker, Inc. (WRBY)](/topic/$wrby) [Unicycive Therapeutics, Inc. (UNCY)](/topic/$uncy) [Day One Biopharmaceuticals, Inc. (DAWN)](/topic/$dawn) [GitLab Inc. (GTLB)](/topic/$gtlb) [Core Scientific, Inc. Common Stock (CORZ)](/topic/$corz) [AB (prev. Newton) (AB)](/topic/$ab) [Intuitive Machines, Inc. (LUNR)](/topic/$lunr) [Carnival Corp (CCL)](/topic/$ccl) [Pfizer, Inc. (PFE)](/topic/$pfe) [Landwolf (WOLF)](/topic/$wolf) [ALX Oncology Holdings Inc (ALXO)](/topic/$alxo) [2131KOBUSHIDE (21)](/topic/$21) [Immix Biopharma, Inc.  (IMMX)](/topic/$immx) [Ramaco Resources, Inc. Common Stock (METC)](/topic/$metc) [Abivax SA (ABVX)](/topic/$abvx) [Brookdale Senior Living, Inc. (BKD)](/topic/$bkd) [nLIGHT, Inc. Common Stock (LASR)](/topic/$lasr) [Taysha Gene Therapies, Inc. (TSHA)](/topic/$tsha) [Immunome, Inc. (IMNM)](/topic/$imnm) [Evommune, Inc. (EVMN)](/topic/$evmn) [Context Therapeutics Inc. (CNTX)](/topic/$cntx) [Immuneering Corporation (IMRX)](/topic/$imrx) [Fractyl Health, Inc. (GUTS)](/topic/$guts) [Cullinan Management, Inc. (CGEM)](/topic/$cgem) [Annexon, Inc. (ANNX)](/topic/$annx) [TScan Therapeutics, Inc.  (TCRX)](/topic/$tcrx) [Ventyx Biosciences, Inc. (VTYX)](/topic/$vtyx) [Rocket Companies, Inc. (RKT)](/topic/$rkt) [Anteris Technologies Global Corp. (AVR)](/topic/$avr) [Venture Global, Inc (VG)](/topic/$vg) [Coterra Energy Inc (CTRA)](/topic/$ctra) [UnitedHealth Group (UNH)](/topic/$unh) [Lumen Technologies Inc (LUMN)](/topic/$lumn) [Bloom Energy Corporation (BE)](/topic/$be) [Eli Lilly and Company (LLY)](/topic/$lly) [Lumentum Holdings Inc. Common Stock (LITE)](/topic/$lite) [GoodRx Holdings, Inc. (GDRX)](/topic/$gdrx) [Canton (CC)](/topic/$cc) [Fermi Inc. (FRMI)](/topic/$frmi)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$CNTX Piper Sandler Initiates Coverage On Context Therapeutics with Overweight Rating Announces Price Target of $4.5 $CNTX DeepTrack 9.89% https://t.co/ci2IWz6ZuT $CNTX DeepTrack 9.89% https://t.co/ci2IWz6ZuT"  
[X Link](https://x.com/zohmbastic/status/1791067913677312014)  2024-05-16T11:27Z 10.1K followers, [----] engagements


"$IMRX Immuneering Corporation (Nasdaq: IMRX) a clinical-stage oncology company focused on keeping cancer patients alive today announced a clinical supply agreement with Eli Lilly and Company (NYSE:LLY) for its second-generation KRAS G12C inhibitor olomorasib (LY3537982). The supply agreement supports the evaluation of Immuneerings lead product candidate atebimetinib (IMM-1-104) a novel dual MEK inhibitor in combination with olomorasib in a planned Phase [--] clinical trial in patients with locally advanced or metastatic KRAS G12c-mutant non-small cell lung cancer (NSCLC) who have progressed on"  
[X Link](https://x.com/zohmbastic/status/1959949093536481484)  2025-08-25T12:00Z 10.1K followers, [----] engagements


"$MBX MBX Biosciences to Provide Topline Results from its Phase [--] Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday September 22"  
[X Link](https://x.com/zohmbastic/status/1969134560471318722)  2025-09-19T20:20Z 10.1K followers, [----] engagements


"$NRXS trimmed some $NRXS 510k https://t.co/MIIfCecwHv $NRXS 510k https://t.co/MIIfCecwHv"  
[X Link](https://x.com/zohmbastic/status/1981693088969163067)  2025-10-24T12:03Z 10K followers, [----] engagements


"$GUTS Canaccord raised the firm's price target on Fractyl Health to $8 from $6 and keeps a Buy rating on the shares. The firm said the company's 3Q25 report was incremental following REMAIN-1 data in Sept which surprised to the upside. After digesting the data the firm increaed its POS to 70% from 60% and doubling our peak penetration to 2% from 1% for Revita ahead of a catalyst heavy 4Q25/1Q26. https://twitter.com/i/web/status/1991846738303259005 https://twitter.com/i/web/status/1991846738303259005"  
[X Link](https://x.com/zohmbastic/status/1991846738303259005)  2025-11-21T12:30Z 10.1K followers, 17K engagements


"$CGEM $CGEM Lynx1 $1.4M worth at [---] https://t.co/g2JEBqr2ra $CGEM Lynx1 $1.4M worth at [---] https://t.co/g2JEBqr2ra"  
[X Link](https://x.com/zohmbastic/status/1991913745032044773)  2025-11-21T16:56Z 10K followers, [----] engagements


"$SG $SG hit 6.6s today https://t.co/thizNVnCeB $SG hit 6.6s today https://t.co/thizNVnCeB"  
[X Link](https://x.com/zohmbastic/status/1991966164516565355)  2025-11-21T20:25Z 10.1K followers, [----] engagements


"$ANNX https://www.sec.gov/Archives/edgar/data/1315797/000131579725000007/xslF345X05/form4-11222025_021158.xml $ANNX wen [--] https://t.co/jddlOdPYRT https://www.sec.gov/Archives/edgar/data/1315797/000131579725000007/xslF345X05/form4-11222025_021158.xml $ANNX wen [--] https://t.co/jddlOdPYRT"  
[X Link](https://x.com/zohmbastic/status/1992942039106011554)  2025-11-24T13:03Z 10K followers, [----] engagements


"$CGEM $CGEM termination on discontinued study On November [--] [----] in connection with its decision not to pursue further development of CLN-617 Cullinan Amber Corp. (the "Company") a subsidiary of Cullinan Therapeutics Inc. notified Massachusetts Institute of Technology ("MIT") of $CGEM termination on discontinued study On November [--] [----] in connection with its decision not to pursue further development of CLN-617 Cullinan Amber Corp. (the "Company") a subsidiary of Cullinan Therapeutics Inc. notified Massachusetts Institute of Technology ("MIT") of"  
[X Link](https://x.com/zohmbastic/status/1992972860726358029)  2025-11-24T15:05Z 10.1K followers, [----] engagements


"$GAP 25c decent so far too $GAP https://t.co/tkEyflTUjn $GAP https://t.co/tkEyflTUjn"  
[X Link](https://x.com/zohmbastic/status/1993384831548522729)  2025-11-25T18:22Z 10K followers, [----] engagements


"$ACVA decent vol pop $ACVA locked a few 7.4s https://t.co/5c8Ugz4OaE $ACVA locked a few 7.4s https://t.co/5c8Ugz4OaE"  
[X Link](https://x.com/zohmbastic/status/1993783555701510625)  2025-11-26T20:46Z 10.1K followers, [----] engagements


"$MLCO $MLCO ww especially after regular session open Casino sector doing well has presence in Asia quite positive looking ER # across Macau Cyprus Philliphines region. Melco Resorts and Enter Q3 Adj. EPS $0.21 Beats $0.12 Estimate Sales $1.309B Beat $1.282B Estimate $MLCO ww especially after regular session open Casino sector doing well has presence in Asia quite positive looking ER # across Macau Cyprus Philliphines region. Melco Resorts and Enter Q3 Adj. EPS $0.21 Beats $0.12 Estimate Sales $1.309B Beat $1.282B Estimate"  
[X Link](https://x.com/zohmbastic/status/1995504572111233259)  2025-12-01T14:45Z 10.1K followers, [----] engagements


"$ANVS stopped out will revisit $ANVS will prob lock a few https://t.co/rk2HSnply5 $ANVS will prob lock a few https://t.co/rk2HSnply5"  
[X Link](https://x.com/zohmbastic/status/1995551700166353118)  2025-12-01T17:52Z 10K followers, [----] engagements


"$BLND vs 3-3.05 zone"  
[X Link](https://x.com/zohmbastic/status/1996590632937120176)  2025-12-04T14:41Z 10K followers, 11.1K engagements


"$BLND $BLND vs 3-3.05 zone https://t.co/4kRtBl0413 $BLND vs 3-3.05 zone https://t.co/4kRtBl0413"  
[X Link](https://x.com/zohmbastic/status/1996593308466868482)  2025-12-04T14:51Z 10K followers, [----] engagements


"$NKLR former $GSRT nuclear sector rotation BRiley had $10 PT"  
[X Link](https://x.com/zohmbastic/status/1996604056433815756)  2025-12-04T15:34Z 10K followers, [----] engagements


"$BMEA BMEA Biomea Fusion Reports Durable Glycemic And C-Peptide Improvements [--] Months After Last Dose In COVALENT-111 With Icovamenib $BMEA https://t.co/AJjw0UObjO $BMEA https://t.co/AJjw0UObjO"  
[X Link](https://x.com/zohmbastic/status/1996934978723012619)  2025-12-05T13:29Z 10.1K followers, [----] engagements


"$CNX Jan 38c large sweep"  
[X Link](https://x.com/zohmbastic/status/1996985685954171293)  2025-12-05T16:51Z 10.1K followers, [---] engagements


"$OCUL H.C. Wainwright raised the firm's price target on Ocular Therapeutix to $21 from $19 and keeps a Buy rating on the shares. RBC RAISES TARGET PRICE TO $30 FROM $24"  
[X Link](https://x.com/zohmbastic/status/1998011032602660880)  2025-12-08T12:45Z 10.1K followers, [----] engagements


"$CGEM decent intra vol $CGEM that 15c up quite a bit https://t.co/yE86A09AOu $CGEM that 15c up quite a bit https://t.co/yE86A09AOu"  
[X Link](https://x.com/zohmbastic/status/1998053519601918306)  2025-12-08T15:34Z 10.1K followers, [----] engagements


"$IMMX what a run ever since break ;) H.C. WAINWRIGHT RAISES TARGET PRICE TO $12 FROM $8 $IMMX a few more https://t.co/bE03zImVwM $IMMX a few more https://t.co/bE03zImVwM"  
[X Link](https://x.com/zohmbastic/status/1998415229114560744)  2025-12-09T15:31Z 10.1K followers, [----] engagements


"$SG decent come back one of sqz candidates $SG https://t.co/AzwIKkDENB $SG https://t.co/AzwIKkDENB"  
[X Link](https://x.com/zohmbastic/status/1998454286200504462)  2025-12-09T18:06Z 10.1K followers, [----] engagements


"$IMMX Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Financing includes leading U.S. biotechnology institutional investors and mutual funds Morgan Stanley was a book-running manager $IMMX near [--] $IMMX near 7"  
[X Link](https://x.com/zohmbastic/status/1998549245750817054)  2025-12-10T00:24Z 10.1K followers, [----] engagements


"$IMMX $3 run ever since daily break $IMMX https://t.co/w4RggMrHYA $IMMX https://t.co/w4RggMrHYA"  
[X Link](https://x.com/zohmbastic/status/1998776870268018705)  2025-12-10T15:28Z 10.1K followers, [----] engagements


"$GEMI Gemini Receives US License for Prediction Markets"  
[X Link](https://x.com/zohmbastic/status/1998869300342567308)  2025-12-10T21:35Z 10K followers, [----] engagements


"$GEMI pcr .164 $GEMI Gemini Receives US License for Prediction Markets $GEMI Gemini Receives US License for Prediction Markets"  
[X Link](https://x.com/zohmbastic/status/1999155524906983539)  2025-12-11T16:33Z 10K followers, [----] engagements


"$IMMX now well above IPO price $5 $IMMX director Nancy Chang holds 422k shs directly and total about 500k shs. Awarded stock 40k options with [----] exercise price vesting in [--] months Chang was Tanox founder which later acquired by Genetech back in [----] https://www.sec.gov/Archives/edgar/data/1135041/000149315225027329/xslF345X05/ownership.xml $IMMX $3 run ever since daily break https://t.co/sMMLtI9zVh https://www.sec.gov/Archives/edgar/data/1135041/000149315225027329/xslF345X05/ownership.xml $IMMX $3 run ever since daily break https://t.co/sMMLtI9zVh"  
[X Link](https://x.com/zohmbastic/status/1999500138251792610)  2025-12-12T15:22Z 10.1K followers, [----] engagements


"$WEST insiders base formed"  
[X Link](https://x.com/zohmbastic/status/1999516957045842418)  2025-12-12T16:29Z 10.1K followers, [---] engagements


"$OLMA $OLMA Citi raised the firm's price target on Olema Oncology (OLMA) to $60 from $21 and keeps a Buy rating on the shares. Citi also added an "upside 90-day catalyst watch" on Olema. The firm says Roche's (RHHBY) positive Phase [--] lidERA trial data shows the "practice changing" $OLMA Citi raised the firm's price target on Olema Oncology (OLMA) to $60 from $21 and keeps a Buy rating on the shares. Citi also added an "upside 90-day catalyst watch" on Olema. The firm says Roche's (RHHBY) positive Phase [--] lidERA trial data shows the "practice changing""  
[X Link](https://x.com/zohmbastic/status/2000582240661541041)  2025-12-15T15:02Z 10.1K followers, [----] engagements


"$INAB PIPE priced [----] $20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619 IN8bios novel gamma-delta () T cell engager through an Investigational New Drug (IND) application Financing led by Coastlands Capital with participation from new and existing biotechnology investors Initial proceeds extend cash runway into the first half of [----] https://twitter.com/i/web/status/2002001384120426789 https://twitter.com/i/web/status/2002001384120426789"  
[X Link](https://x.com/zohmbastic/status/2002001384120426789)  2025-12-19T13:01Z 10.1K followers, [----] engagements


"$IVVD BTIG analyst Thomas Shrader initiated coverage of Invivyd with a Buy rating and $10 price target. The company has a proven track record of producing effective antibodies the analyst tells investors in a research note. The firm believes Invivyd's VYD2311 offers a "much larger" total addressable market relative to Pemgarda. $IVVD https://t.co/e7qjEdhteY $IVVD https://t.co/e7qjEdhteY"  
[X Link](https://x.com/zohmbastic/status/2003159923283361839)  2025-12-22T17:45Z 10.1K followers, [----] engagements


"$CZR $CZR some Jan spread trades pcr .168 https://t.co/zTtZ9rkNf6 $CZR some Jan spread trades pcr .168 https://t.co/zTtZ9rkNf6"  
[X Link](https://x.com/zohmbastic/status/2003198126828769760)  2025-12-22T20:17Z 10K followers, [----] engagements


"$TCRX $TCRX https://t.co/Pd2aJfvl2L $TCRX https://t.co/Pd2aJfvl2L"  
[X Link](https://x.com/zohmbastic/status/2003851523684716743)  2025-12-24T15:33Z 10K followers, [----] engagements


"$INAB $INAB PIPE priced [----] $20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619 IN8bios novel gamma-delta () T cell engager through an Investigational New Drug (IND) application Financing led by Coastlands Capital with participation from $INAB PIPE priced [----] $20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619 IN8bios novel gamma-delta () T cell engager through an Investigational New Drug (IND) application Financing led by Coastlands Capital with participation from"  
[X Link](https://x.com/zohmbastic/status/2003879122414788914)  2025-12-24T17:23Z 10.1K followers, [----] engagements


"$TCRX $TCRX https://t.co/Pd2aJfvl2L $TCRX https://t.co/Pd2aJfvl2L"  
[X Link](https://x.com/zohmbastic/status/2004628908080247032)  2025-12-26T19:02Z 10.1K followers, [----] engagements


"$ALHC strong eod"  
[X Link](https://x.com/zohmbastic/status/2006107871134482536)  2025-12-30T20:59Z 10K followers, [----] engagements


"$WULF Keefe Bruyette upgraded TeraWulf to Outperform from Market Perform with a price target of $24 up from $9.50. The firm believes investors are underestimating the magnitude of TeraWulf's bitcoin mining to high performance compute leasing mix shift in [----] and [----]. The company's existing leases can drive 505% annual EBITDA growth through [----] and a "positive inflection" in pre-tax return on invested capital enabling multiple expansion the analyst tells investors in a research note. Keefe sees a "compelling risk/reward asymmetry" at current share levels."  
[X Link](https://x.com/zohmbastic/status/2006344351157244321)  2025-12-31T12:39Z 10.1K followers, [----] engagements


"$ALHC $ALHC strong eod https://t.co/2YhaWDGnCi $ALHC strong eod https://t.co/2YhaWDGnCi"  
[X Link](https://x.com/zohmbastic/status/2006399581215392074)  2025-12-31T16:18Z 10K followers, [----] engagements


"$ALHC [--] $ALHC https://t.co/pamNtz7cG5 $ALHC https://t.co/pamNtz7cG5"  
[X Link](https://x.com/zohmbastic/status/2007152504606527881)  2026-01-02T18:10Z 10K followers, [----] engagements


"$GUTS Fractyl Health outlined its strategic outlook for [----] highlighting anticipated clinical and regulatory milestones across its Revita and Rejuva programs. "As we enter [----] we believe Fractyl is positioned for a definitional year and our focus is on disciplined execution with an accelerating cadence of clinical and regulatory milestones and progress" said Harith Rajagopalan M.D. Ph.D. Co-Founder and Chief Executive Officer of Fractyl Health. "We are rapidly advancing Revita as an outpatient endoscopic therapy designed to address a root cause of obesity. This year we expect to deliver"  
[X Link](https://x.com/zohmbastic/status/2008167396314390901)  2026-01-05T13:23Z 10.1K followers, [----] engagements


"$OSCR Barclays analyst Andrew Mok upgraded Oscar Health to Equal Weight from Underweight with a price target of $18 up from $13. The firm sees managed care stocks benefiting in [----] from the prospects of margin expansion and rotation away from artificial intelligence-related stocks toward "de-rated underperformers." Oscar is priced attractively as the market is currently over-discounting the negative outcomes from expiring subsidies the analyst tells investors in a research note. https://twitter.com/i/web/status/2008170881537671659 https://twitter.com/i/web/status/2008170881537671659"  
[X Link](https://x.com/zohmbastic/status/2008170881537671659)  2026-01-05T13:37Z 10.1K followers, [----] engagements


"$snps $SNPS https://t.co/XKq6AjWHlE $SNPS https://t.co/XKq6AjWHlE"  
[X Link](https://x.com/zohmbastic/status/2008202224854569449)  2026-01-05T15:41Z 10K followers, [----] engagements


"$ANNX daily decent come back $ANNX https://t.co/oZcIT0MivQ $ANNX https://t.co/oZcIT0MivQ"  
[X Link](https://x.com/zohmbastic/status/2008278301979136491)  2026-01-05T20:43Z 10.1K followers, [----] engagements


"$HSAI lidar name in china"  
[X Link](https://x.com/zohmbastic/status/2008555629234073786)  2026-01-06T15:05Z 10.1K followers, [----] engagements


"$HSAI near [--] $HSAI lidar name in china https://t.co/N0q96XW6s2 $HSAI lidar name in china https://t.co/N0q96XW6s2"  
[X Link](https://x.com/zohmbastic/status/2008588056333611019)  2026-01-06T17:14Z 10.1K followers, [----] engagements


"$UA $UAA $UA 13D 41.9M 22.2% https://t.co/Is3bekp7Nr $UA 13D 41.9M 22.2% https://t.co/Is3bekp7Nr"  
[X Link](https://x.com/zohmbastic/status/2008624049685971344)  2026-01-06T19:37Z 10K followers, [----] engagements


"$BIOA $BIOA https://t.co/193uoRJuK9 $BIOA https://t.co/193uoRJuK9"  
[X Link](https://x.com/zohmbastic/status/2008641259733426276)  2026-01-06T20:46Z 10K followers, [----] engagements


"$BIOA [--] holla $BIOA 16s in ah $BIOA 16s in ah"  
[X Link](https://x.com/zohmbastic/status/2008654426207351069)  2026-01-06T21:38Z 10K followers, [----] engagements


"$BIOA fyi BIOA ipo was at $18 $BIOA [--] holla $BIOA [--] holla"  
[X Link](https://x.com/zohmbastic/status/2008659587180986878)  2026-01-06T21:58Z 10K followers, [----] engagements


"$OLMA Piper Sandler initiated coverage of Olema Oncology with an Overweight rating and $40 price target. The firm believes the company's palazestrant can become the next "backbone" endocrine therapy in the large ER+/HER2- breast cancer market. $OLMA Citi raised the firm's price target on Olema Oncology (OLMA) to $60 from $21 and keeps a Buy rating on the shares. Citi also added an "upside 90-day catalyst watch" on Olema. The firm says Roche's (RHHBY) positive Phase [--] lidERA trial data shows the "practice changing" $OLMA Citi raised the firm's price target on Olema Oncology (OLMA) to $60 from"  
[X Link](https://x.com/zohmbastic/status/2008890117197566153)  2026-01-07T13:15Z 10.1K followers, [----] engagements


"$HSAI pcr .223 for now $HSAI near [--] $HSAI near 27"  
[X Link](https://x.com/zohmbastic/status/2008967190515789853)  2026-01-07T18:21Z 10.1K followers, [----] engagements


"$WRBY nicely ITM $WRBY 27s hit today https://t.co/4GudJhbI3p $WRBY 27s hit today https://t.co/4GudJhbI3p"  
[X Link](https://x.com/zohmbastic/status/2008971809455264215)  2026-01-07T18:39Z 10K followers, [----] engagements


"$OLMA daily curl $OLMA Piper Sandler initiated coverage of Olema Oncology with an Overweight rating and $40 price target. The firm believes the company's palazestrant can become the next "backbone" endocrine therapy in the large ER+/HER2- breast cancer market. $OLMA Piper Sandler initiated coverage of Olema Oncology with an Overweight rating and $40 price target. The firm believes the company's palazestrant can become the next "backbone" endocrine therapy in the large ER+/HER2- breast cancer market"  
[X Link](https://x.com/zohmbastic/status/2009003718717657343)  2026-01-07T20:46Z 10.1K followers, [----] engagements


"$VTYX Under the terms of the agreement Lilly will acquire all of the outstanding shares of Ventyx for $14.00 per share of common stock in an all-cash transaction (equal to an aggregate equity value of approximately $1.2 billion). The transaction is not subject to any financing condition and is expected to close in the first half of [----] subject to approval by Ventyx stockholders and satisfaction of other customary closing conditions including regulatory approvals. $VTYX overnight session hit 19s VTYX UBS initiated coverage of Ventyx Biosciences with a Buy rating and $20 price target as the"  
[X Link](https://x.com/zohmbastic/status/2009011996935471290)  2026-01-07T21:19Z 10K followers, 17.2K engagements


"$SKYX NVIDIA Connect Supports Advanced Technology Companies Developing AI-powered Products Part of NVIDIAs Connect Program is to Promote Assist and Identify Go-To-Market Opportunities SKYX Expects to Include its All-In-One Smart Platform and Hub in Collaboration with NVIDIAs AI Features in Future U.S. and Global Projects Including the Upcoming $4 Billion Miami Florida Smart City NVIDIA Connect is Designed to Help Build AI Solutions Faster Accelerate Growth and Maximize Opportunities while Delivering a Range of Significant AI Ecosystem Advantages as Well as Free Benefits SKYXs Technologies"  
[X Link](https://x.com/zohmbastic/status/2009251978992300307)  2026-01-08T13:12Z 10.1K followers, [----] engagements


"$HSAI decent intra flow $HSAI pcr .223 for now https://t.co/6OOp598kVR $HSAI pcr .223 for now https://t.co/6OOp598kVR"  
[X Link](https://x.com/zohmbastic/status/2009284612371960064)  2026-01-08T15:22Z 10.1K followers, [----] engagements


"$GAP $GAP https://t.co/1yz1xvaMLs $GAP https://t.co/1yz1xvaMLs"  
[X Link](https://x.com/zohmbastic/status/2009299896621207745)  2026-01-08T16:23Z 10.1K followers, [----] engagements


"$WRBY $WRBY nicely ITM https://t.co/qpWFdOEtq6 $WRBY nicely ITM https://t.co/qpWFdOEtq6"  
[X Link](https://x.com/zohmbastic/status/2009320016836219128)  2026-01-08T17:43Z 10K followers, [----] engagements


"$CZR $CZR some Jan spread trades pcr .168 https://t.co/zTtZ9rkNf6 $CZR some Jan spread trades pcr .168 https://t.co/zTtZ9rkNf6"  
[X Link](https://x.com/zohmbastic/status/2009320676151435326)  2026-01-08T17:45Z 10.1K followers, [----] engagements


"$UA $UAA another good day $UA $UAA decent eod $UA $UAA decent eod"  
[X Link](https://x.com/zohmbastic/status/2009367617526460636)  2026-01-08T20:52Z 10K followers, [----] engagements


"$RKT $UWMC $OPEN etc popping on Trump comment"  
[X Link](https://x.com/zohmbastic/status/2009377973049131480)  2026-01-08T21:33Z 10K followers, 12K engagements


"$OLMA back to [--] $OLMA daily curl https://t.co/kWflBZEFDq $OLMA daily curl https://t.co/kWflBZEFDq"  
[X Link](https://x.com/zohmbastic/status/2009728586308067469)  2026-01-09T20:46Z 10.1K followers, [----] engagements


"$BIOA $BIOA fyi BIOA ipo was at $18 $BIOA fyi BIOA ipo was at $18"  
[X Link](https://x.com/zohmbastic/status/2010722963772121307)  2026-01-12T14:38Z 10K followers, [----] engagements


"$DAWN pretty break $DAWN https://t.co/VWR63qAxZq $DAWN https://t.co/VWR63qAxZq"  
[X Link](https://x.com/zohmbastic/status/2010725139714023540)  2026-01-12T14:46Z 10K followers, [----] engagements


"$BILI $BILI https://t.co/fw8o9YCSTj $BILI https://t.co/fw8o9YCSTj"  
[X Link](https://x.com/zohmbastic/status/2010738849488814436)  2026-01-12T15:41Z 10.1K followers, [----] engagements


"$BILI [--] holla $BILI had 31c on china strength decent so far https://t.co/GHfoRRjiRI $BILI had 31c on china strength decent so far https://t.co/GHfoRRjiRI"  
[X Link](https://x.com/zohmbastic/status/2010803796168073529)  2026-01-12T19:59Z 10K followers, [----] engagements


"$RVMD After Revolution Medicines (RVMD) presented pipeline updates and its [----] outlook at a competitor conference in the wake of a report that Merck (MRK) is in talks to acquire Revolution for $28B-$32B Stifel analyst Laura Prendergast said the updates "have us thinking that this speculated $28-32B range might not be enough." As a company policy Revolution does not comment on rumors or speculation notes the analyst whose target price and Buy rating are currently under review as the firm further evaluates the impact of this Revolution M&A speculation and today's updates. $RVMD"  
[X Link](https://x.com/zohmbastic/status/2010811121544872106)  2026-01-12T20:28Z 10K followers, [----] engagements


"$WRBY $WRBY https://t.co/7NaJL72NaJ $WRBY https://t.co/7NaJL72NaJ"  
[X Link](https://x.com/zohmbastic/status/2011087563834945731)  2026-01-13T14:46Z 10.1K followers, [----] engagements


"$WRBY $WRBY https://t.co/0Y7ppI30cj $WRBY https://t.co/0Y7ppI30cj"  
[X Link](https://x.com/zohmbastic/status/2011091155245535444)  2026-01-13T15:01Z 10.1K followers, [----] engagements


"$WRBY 30-31 should be key zone $WRBY https://t.co/oe9cP6M51b $WRBY https://t.co/oe9cP6M51b"  
[X Link](https://x.com/zohmbastic/status/2011092908414308626)  2026-01-13T15:08Z 10.1K followers, [----] engagements


"$BIOA not bad $BIOA https://t.co/iRTunKUKEZ $BIOA https://t.co/iRTunKUKEZ"  
[X Link](https://x.com/zohmbastic/status/2011147833412583571)  2026-01-13T18:46Z 10K followers, [----] engagements


"$ANNX $ANNX daily decent come back https://t.co/ktqSDlKSdc $ANNX daily decent come back https://t.co/ktqSDlKSdc"  
[X Link](https://x.com/zohmbastic/status/2011150521164579232)  2026-01-13T18:57Z 10.1K followers, [----] engagements


"$ALMS so far $ALMS https://t.co/YL1CiMSVbK $ALMS https://t.co/YL1CiMSVbK"  
[X Link](https://x.com/zohmbastic/status/2011159340007453116)  2026-01-13T19:32Z 10K followers, [----] engagements


"$IMRX insider https://www.sec.gov/Archives/edgar/data/1790340/000179034026000008/xslF345X05/wk-form4_1768396231.xml https://www.sec.gov/Archives/edgar/data/1790340/000179034026000008/xslF345X05/wk-form4_1768396231.xml"  
[X Link](https://x.com/zohmbastic/status/2011432262420844933)  2026-01-14T13:36Z 10.1K followers, [----] engagements


"$WRBY $WRBY 30-31 should be key zone $WRBY 30-31 should be key zone"  
[X Link](https://x.com/zohmbastic/status/2011456523156017180)  2026-01-14T15:13Z 10.1K followers, [----] engagements


"$UNCY $UNCY https://t.co/P4nRI6pCQH $UNCY https://t.co/P4nRI6pCQH"  
[X Link](https://x.com/zohmbastic/status/2011460014905684170)  2026-01-14T15:26Z 10.1K followers, [----] engagements


"$alms hearing rumor that alms is over [--] $ALMS 7.5c over 1000% https://t.co/Tgj1JnkSmp $ALMS 7.5c over 1000% https://t.co/Tgj1JnkSmp"  
[X Link](https://x.com/zohmbastic/status/2011483718892781876)  2026-01-14T17:01Z 10K followers, [----] engagements


"$UNCY intra high $UNCY https://t.co/XvKp8MRUJe $UNCY https://t.co/XvKp8MRUJe"  
[X Link](https://x.com/zohmbastic/status/2011498472868921374)  2026-01-14T17:59Z 10.1K followers, [----] engagements


"$RPID $RPID took some 3.3s will risk 2.8s zone Fourth quarter [----] total revenue expected to be approximately $11.3 million representing growth of approximately 37% compared to the prior-year period. Received record multi-system order in the fourth quarter from an existing Top [--] $RPID took some 3.3s will risk 2.8s zone Fourth quarter [----] total revenue expected to be approximately $11.3 million representing growth of approximately 37% compared to the prior-year period. Received record multi-system order in the fourth quarter from an existing Top 20"  
[X Link](https://x.com/zohmbastic/status/2011500180869362076)  2026-01-14T18:06Z 10K followers, [----] engagements


"$AA $CENX $AA Feb 65c big sweep large premium $AA Feb 65c big sweep large premium"  
[X Link](https://x.com/zohmbastic/status/2011517012993065285)  2026-01-14T19:13Z 10.1K followers, [----] engagements


"$UAA $UA $UA $UAA another good day https://t.co/8vzkSVkiMd $UA $UAA another good day https://t.co/8vzkSVkiMd"  
[X Link](https://x.com/zohmbastic/status/2011519289753551234)  2026-01-14T19:22Z 10.1K followers, [----] engagements


"$ANNX $ANNX https://t.co/5nv1prcSGP $ANNX https://t.co/5nv1prcSGP"  
[X Link](https://x.com/zohmbastic/status/2011533568087060659)  2026-01-14T20:19Z 10.1K followers, [----] engagements


"$RPID decent eod $RPID https://t.co/QKjgiKTlBA $RPID https://t.co/QKjgiKTlBA"  
[X Link](https://x.com/zohmbastic/status/2011543045817450684)  2026-01-14T20:56Z 10K followers, [----] engagements


"$MNMD -- $DFTX $MNMD back to [--] holla $MNMD back to [--] holla"  
[X Link](https://x.com/zohmbastic/status/2011779040789614679)  2026-01-15T12:34Z 10K followers, [----] engagements


"$ZETA Morgan Stanley raised the firm's price target on Zeta Global to $27 from $23. Application SaaS names underperformed both the broader software group and the technology sector in [----] but evidence is building that AI-related risks may prove less severe than initially feared supporting a more constructive outlook for application SaaS in [----] the analyst tells investors in a look-ahead note for the group. However a continued lack of broad-based positive spending revisions keeps the firm "selectively opportunistic" the analyst added. $ZETA https://t.co/tPjd2WQ814 $ZETA https://t.co/tPjd2WQ814"  
[X Link](https://x.com/zohmbastic/status/2011780549761802480)  2026-01-15T12:40Z 10.1K followers, 11K engagements


"$ERAS $ERAS [--] holla https://t.co/5sssRzAIWM $ERAS [--] holla https://t.co/5sssRzAIWM"  
[X Link](https://x.com/zohmbastic/status/2011834872470425743)  2026-01-15T16:16Z 10K followers, [----] engagements


"$ERAS fentolla $ERAS https://t.co/91ofCikcjz $ERAS https://t.co/91ofCikcjz"  
[X Link](https://x.com/zohmbastic/status/2011835312855519712)  2026-01-15T16:18Z 10K followers, [----] engagements


"$HSAI nice break $HSAI lidar name in china https://t.co/N0q96XW6s2 $HSAI lidar name in china https://t.co/N0q96XW6s2"  
[X Link](https://x.com/zohmbastic/status/2011846966549102851)  2026-01-15T17:04Z 10.1K followers, [----] engagements


"$BILI $BILI [--] holla $BILI [--] holla"  
[X Link](https://x.com/zohmbastic/status/2011859449875513602)  2026-01-15T17:54Z 10.1K followers, [----] engagements


"$BILI pcr .103 today $BILI https://t.co/bdd3nA0dP2 $BILI https://t.co/bdd3nA0dP2"  
[X Link](https://x.com/zohmbastic/status/2011866875127361826)  2026-01-15T18:23Z 10K followers, [----] engagements


"$BTDR intra high $BTDR https://t.co/Zs5jeU5bWL $BTDR https://t.co/Zs5jeU5bWL"  
[X Link](https://x.com/zohmbastic/status/2011891248915984509)  2026-01-15T20:00Z 10.1K followers, [----] engagements


"$BIOA stopped remaining $bioa [--] $bioa 24"  
[X Link](https://x.com/zohmbastic/status/2011893400384241702)  2026-01-15T20:09Z 10.1K followers, [----] engagements


"$ERAS Piper Sandler raised the firm's price target on Erasca to $11 from $5 and keeps an Overweight rating on the shares. Following a flurry of updates from companies across its coverage the firm updating its [----] Catalyst Tracker as well as several models and price targets. $ERAS fentolla https://t.co/pKjlmCBQSs $ERAS fentolla https://t.co/pKjlmCBQSs"  
[X Link](https://x.com/zohmbastic/status/2012147766022242714)  2026-01-16T12:59Z 10K followers, [----] engagements


"$ONDS Ondas expects to report revenue of $27.0 to $29.0 million for the quarter ended December [--] [----] 51% higher than the prior Q4 [----] revenue target. For the full year ended December [--] [----] expected revenue is between $47.6 and $49.6 million 23% higher than the prior full-year revenue target for [----]. Ondas' prior revenue targets for Q4 [----] and full-year [----] included a contribution of $3 - [--] million for Roboteam which closed in December [----]. Additionally on a preliminary basis Ondas' estimated backlog is $65.3 million as of December [--] [----] a 180% increase from $23.3 million on"  
[X Link](https://x.com/zohmbastic/status/2012150370693235054)  2026-01-16T13:10Z 10K followers, 16.8K engagements


"$LDI $LDI https://t.co/9wou3PPlYB $LDI https://t.co/9wou3PPlYB"  
[X Link](https://x.com/zohmbastic/status/2012177114569527427)  2026-01-16T14:56Z 10.1K followers, [----] engagements


"$BTDR $BTDR https://t.co/Zs5jeU5bWL $BTDR https://t.co/Zs5jeU5bWL"  
[X Link](https://x.com/zohmbastic/status/2012201838318100844)  2026-01-16T16:34Z 10.1K followers, [----] engagements


"$RIOT PTs Piper Sandler [--] Cantor [--] BTIG [--] Clear Street [--] Roth [--] Piper Sandler analyst Patrick Moley reiterated an Overweight rating and $26 price target on Riot Platforms (RIOT) after the company signed a land acquisition and data center lease with AMD (AMD) to host [--] megawatts of critical IT at Rockdale. While the initial deployment is for just [--] MW the firm thinks the deal establishes Riot as a credible data center option for hyperscaler tenants. Piper also views it as an encouraging first step towards Riot eventually contracting all roughly [---] gigawatts of critical IT across"  
[X Link](https://x.com/zohmbastic/status/2012258717908013434)  2026-01-16T20:20Z 10.1K followers, [----] engagements


"$AG nonstop (Periodic table silver symbol) $AU is gold"  
[X Link](https://x.com/zohmbastic/status/2012259330695831918)  2026-01-16T20:23Z 10K followers, [----] engagements


"$ERAS gaining back eod $ERAS Piper Sandler raised the firm's price target on Erasca to $11 from $5 and keeps an Overweight rating on the shares. Following a flurry of updates from companies across its coverage the firm updating its [----] Catalyst Tracker as well as several models and price targets. $ERAS Piper Sandler raised the firm's price target on Erasca to $11 from $5 and keeps an Overweight rating on the shares. Following a flurry of updates from companies across its coverage the firm updating its [----] Catalyst Tracker as well as several models and price targets"  
[X Link](https://x.com/zohmbastic/status/2012262932483019075)  2026-01-16T20:37Z 10K followers, [----] engagements


"$GNRC March 185c large vol into eod"  
[X Link](https://x.com/zohmbastic/status/2012267570657632654)  2026-01-16T20:55Z 10K followers, [---] engagements


"$IPSC Venrock https://www.sec.gov/Archives/edgar/data/1738048/000173804826000002/xslSCHEDULE_13G_X01/primary_doc.xml $IPSC Commodore 13M 7.1% https://t.co/6UdSii2vdU https://www.sec.gov/Archives/edgar/data/1738048/000173804826000002/xslSCHEDULE_13G_X01/primary_doc.xml $IPSC Commodore 13M 7.1% https://t.co/6UdSii2vdU"  
[X Link](https://x.com/zohmbastic/status/2012277137911185426)  2026-01-16T21:33Z 10.1K followers, [----] engagements


"$IPSC Ra many bio funds reporting https://www.sec.gov/Archives/edgar/data/1346824/000134682426000006/xslSCHEDULE_13G_X01/primary_doc.xml $IPSC Venrock https://t.co/cPld1D0dao https://www.sec.gov/Archives/edgar/data/1346824/000134682426000006/xslSCHEDULE_13G_X01/primary_doc.xml $IPSC Venrock https://t.co/cPld1D0dao"  
[X Link](https://x.com/zohmbastic/status/2012278036184326349)  2026-01-16T21:37Z 10.1K followers, [----] engagements


"$IMRX $IMRX insider https://t.co/RmBx5DcCel $IMRX insider https://t.co/RmBx5DcCel"  
[X Link](https://x.com/zohmbastic/status/2013635323788411306)  2026-01-20T15:30Z 10.1K followers, [----] engagements


"$UNCY $UNCY intra high $UNCY intra high"  
[X Link](https://x.com/zohmbastic/status/2013636841044353418)  2026-01-20T15:36Z 10.1K followers, [----] engagements


"$ALMS [--] above key $alms hearing rumor that alms is over [--] $alms hearing rumor that alms is over 24"  
[X Link](https://x.com/zohmbastic/status/2013645798114734140)  2026-01-20T16:12Z 10K followers, [----] engagements


"$DAWN $DAWN pretty break https://t.co/ORxy02ceHV $DAWN pretty break https://t.co/ORxy02ceHV"  
[X Link](https://x.com/zohmbastic/status/2013688889827799151)  2026-01-20T19:03Z 10K followers, [----] engagements


"$KVUE intra high $KVUE https://t.co/wdM3yuecY3 $KVUE https://t.co/wdM3yuecY3"  
[X Link](https://x.com/zohmbastic/status/2013693464114823428)  2026-01-20T19:21Z 10K followers, [----] engagements


"$DAWN nice break $DAWN https://t.co/zJru933otu $DAWN https://t.co/zJru933otu"  
[X Link](https://x.com/zohmbastic/status/2013706339667558702)  2026-01-20T20:12Z 10.1K followers, [----] engagements


"$KVUE trimmed a few $KVUE intra high $KVUE intra high"  
[X Link](https://x.com/zohmbastic/status/2013713549059674159)  2026-01-20T20:41Z 10K followers, [----] engagements


"$ALMS [--] got avged up with call exercise $ALMS [--] above key https://t.co/k3HaxSS8L0 $ALMS [--] above key https://t.co/k3HaxSS8L0"  
[X Link](https://x.com/zohmbastic/status/2013714116217655661)  2026-01-20T20:43Z 10K followers, [----] engagements


"$ERAS another one that should get good pricing. still holding with call exercise Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers today announced that it intends to offer and sell subject to market and other conditions $150.0 million of shares of its common stock in a proposed underwritten public offering. All of the shares of common stock to be sold in the proposed offering are being offered by Erasca. In addition Erasca intends to grant the"  
[X Link](https://x.com/zohmbastic/status/2013723047040106644)  2026-01-20T21:19Z 10.1K followers, [----] engagements


"$DAWN 13s hit in AH $DAWN strong eod $DAWN strong eod"  
[X Link](https://x.com/zohmbastic/status/2013776332262408414)  2026-01-21T00:51Z 10K followers, [----] engagements


"$AVR decent into close $AVR $MDT Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic $AVR $MDT Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic"  
[X Link](https://x.com/zohmbastic/status/2013777361850802533)  2026-01-21T00:55Z 10K followers, [----] engagements


"$DAWN $DAWN 13s hit in AH $DAWN 13s hit in AH"  
[X Link](https://x.com/zohmbastic/status/2013985937059926512)  2026-01-21T14:44Z 10.1K followers, [----] engagements


"$METC nearing [--] $METC nice block today https://t.co/8YpOJIEyy2 $METC nice block today https://t.co/8YpOJIEyy2"  
[X Link](https://x.com/zohmbastic/status/2013991434005749823)  2026-01-21T15:05Z 10.1K followers, [----] engagements


"$AMKR nice bnce $AMKR https://t.co/srdHgqwaD1 $AMKR https://t.co/srdHgqwaD1"  
[X Link](https://x.com/zohmbastic/status/2013992187730477136)  2026-01-21T15:08Z 10.1K followers, [----] engagements


"$UAL UNITED CEO - WE MADE A $500 MILLION PROFIT IN CHICAGO BUT OUR COMPETITOR LOST $500 MILLION"  
[X Link](https://x.com/zohmbastic/status/2014013262669504801)  2026-01-21T16:32Z 10.1K followers, [---] engagements


"$ALKS intra vol"  
[X Link](https://x.com/zohmbastic/status/2014033324293956046)  2026-01-21T17:52Z 10.1K followers, [---] engagements


"$UA had 2M block today $UA https://t.co/jREeqxoHLA $UA https://t.co/jREeqxoHLA"  
[X Link](https://x.com/zohmbastic/status/2014034894867841115)  2026-01-21T17:58Z 10.1K followers, [----] engagements


"$ALMS $ALMS Charden initiate coverage with a Buy rating PT of $37 based on the potential of its late-stage clinical pipeline in TYK2-mediated autoimmune disorders. Alumis lead asset envudeucitinib is an oral second-gen allosteric TYK2 inhibitor that recently achieved all primary $ALMS Charden initiate coverage with a Buy rating PT of $37 based on the potential of its late-stage clinical pipeline in TYK2-mediated autoimmune disorders. Alumis lead asset envudeucitinib is an oral second-gen allosteric TYK2 inhibitor that recently achieved all primary"  
[X Link](https://x.com/zohmbastic/status/2014049508057829507)  2026-01-21T18:56Z 10.1K followers, [----] engagements


"$ERAS back above [--] $ERAS another one that should get good pricing. still holding with call exercise Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RAS/MAPK https://t.co/MKi91T85TN $ERAS another one that should get good pricing. still holding with call exercise Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RAS/MAPK https://t.co/MKi91T85TN"  
[X Link](https://x.com/zohmbastic/status/2014072760675315934)  2026-01-21T20:29Z 10.1K followers, [----] engagements


"$VLO VALERO BUYS VENEZUELAN OIL FROM TRADING HOUSE VITOL SOURCE SAYS"  
[X Link](https://x.com/zohmbastic/status/2014139492475588940)  2026-01-22T00:54Z 10K followers, [---] engagements


"$UA https://www.sec.gov/Archives/edgar/data/915191/000094787126000063/xslF345X05/ownership.xml $UA had 2M block today https://www.sec.gov/Archives/edgar/data/915191/000094787126000063/xslF345X05/ownership.xml $UA had 2M block today"  
[X Link](https://x.com/zohmbastic/status/2014143157739409721)  2026-01-22T01:08Z 10.1K followers, [----] engagements


"$ERAS nice pricing Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers today announced the pricing of an upsized public offering of [--------] shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca . The gross proceeds to Erasca from the offering before deducting the underwriting discounts and"  
[X Link](https://x.com/zohmbastic/status/2014328606277685365)  2026-01-22T13:25Z 10.1K followers, [----] engagements


"$RVMD Stifel raised the firm's price target on Revolution Medicines to $170 from $85 and keeps a Buy rating on the shares. In an M&A scenario the firm's target values Revolution at about $36B and at a deal valuation "well within" the historic biotech M&A range the analyst tells investors. In addition to the scarcity value of pan-RAS inhibitors the firm believes the pipeline has a lot of value that is not recognized in five-year forward estimates which it argues could give Revolution "substantial leverage in M&A negotiations" but also drive meaningful near-term upside should the company remain"  
[X Link](https://x.com/zohmbastic/status/2014330780776878199)  2026-01-22T13:34Z 10K followers, [----] engagements


"$KVUE inverse pseudo scientist RFK $KVUE trimmed a few https://t.co/F4CLTqOCTI $KVUE trimmed a few https://t.co/F4CLTqOCTI"  
[X Link](https://x.com/zohmbastic/status/2014360979228741770)  2026-01-22T15:34Z 10K followers, [----] engagements


"$GUTS $GUTS eod vol $GUTS eod vol"  
[X Link](https://x.com/zohmbastic/status/2014366768601399468)  2026-01-22T15:57Z 10K followers, [----] engagements


"$UNCY breaking $UNCY https://t.co/piSmt4aky2 $UNCY https://t.co/piSmt4aky2"  
[X Link](https://x.com/zohmbastic/status/2014367294349050073)  2026-01-22T15:59Z 10.1K followers, [----] engagements


"$RUN bnce continuation"  
[X Link](https://x.com/zohmbastic/status/2014372231145525306)  2026-01-22T16:18Z 10K followers, [----] engagements


"$METC [--] today $METC nearing [--] https://t.co/1Gryq0AXVM $METC nearing [--] https://t.co/1Gryq0AXVM"  
[X Link](https://x.com/zohmbastic/status/2014377374071058929)  2026-01-22T16:39Z 10.1K followers, [----] engagements


"$DAWN intact $DAWN https://t.co/QeRukg5k8I $DAWN https://t.co/QeRukg5k8I"  
[X Link](https://x.com/zohmbastic/status/2014413832374853653)  2026-01-22T19:04Z 10.1K followers, [----] engagements


"$FROG Feb 60c sweep"  
[X Link](https://x.com/zohmbastic/status/2014419773128376364)  2026-01-22T19:27Z 10.1K followers, [----] engagements


"$NKLR another one to watch in the reactor basket $NKLR former $GSRT nuclear sector rotation BRiley had $10 PT https://t.co/4nftGPELy7 $NKLR former $GSRT nuclear sector rotation BRiley had $10 PT https://t.co/4nftGPELy7"  
[X Link](https://x.com/zohmbastic/status/2014421826919690346)  2026-01-22T19:36Z 10.1K followers, [----] engagements


"$GTLB seems overdone bnce play took a few"  
[X Link](https://x.com/zohmbastic/status/2014425362743136660)  2026-01-22T19:50Z 10.1K followers, [----] engagements


"$BHVN $BHVN not a bad move Biohaven Highlights Portfolio Progress Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference https://t.co/rzktoub5lP $BHVN not a bad move Biohaven Highlights Portfolio Progress Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference https://t.co/rzktoub5lP"  
[X Link](https://x.com/zohmbastic/status/2014431891714159100)  2026-01-22T20:16Z 10K followers, [----] engagements


"$VG $VG https://t.co/MG4SgGFiuh $VG https://t.co/MG4SgGFiuh"  
[X Link](https://x.com/zohmbastic/status/2014442153087295863)  2026-01-22T20:56Z 10.1K followers, [----] engagements


"$UA $UAA a bit conservative PT Citi analyst Paul Lejuez raised the firm's price target on Under Armour to $6.50 from $5 and keeps a Neutral rating on the shares. $UA https://t.co/XPSJMLMiSx https://t.co/Ik33I3SBWb $UA https://t.co/XPSJMLMiSx https://t.co/Ik33I3SBWb"  
[X Link](https://x.com/zohmbastic/status/2014683265517457482)  2026-01-23T12:54Z 10.1K followers, [----] engagements


"$CMPS $CMPS https://t.co/eBnZMHkaVh $CMPS https://t.co/eBnZMHkaVh"  
[X Link](https://x.com/zohmbastic/status/2014713578364788736)  2026-01-23T14:55Z 10.1K followers, [----] engagements


"$ABVX $ABVX Morgan Stanley raised the firm's price target on Abivax to $145 from $101 and keeps an Overweight rating on the shares after the company provided its [----] corporate outlook highlighting new market research and clinical progress ahead of next week's investment conference in $ABVX Morgan Stanley raised the firm's price target on Abivax to $145 from $101 and keeps an Overweight rating on the shares after the company provided its [----] corporate outlook highlighting new market research and clinical progress ahead of next week's investment conference in"  
[X Link](https://x.com/zohmbastic/status/2014730277872951582)  2026-01-23T16:01Z 10K followers, [----] engagements


"$BBAR daily $BBAR break https://t.co/2KZLqt8tZ0 $BBAR break https://t.co/2KZLqt8tZ0"  
[X Link](https://x.com/zohmbastic/status/2014730811694628891)  2026-01-23T16:03Z 10.1K followers, [----] engagements


"$QCLS will need to overcome this not soon imo this is $TNFA bio turned into quantum photonics"  
[X Link](https://x.com/zohmbastic/status/2014734865464230136)  2026-01-23T16:19Z 10K followers, [----] engagements


"$FROG $FROG Feb 60c sweep $FROG Feb 60c sweep"  
[X Link](https://x.com/zohmbastic/status/2014735098994725314)  2026-01-23T16:20Z 10.1K followers, [----] engagements


"$IMRX r/g on vol $IMRX https://t.co/EQXZJsZnGi $IMRX https://t.co/EQXZJsZnGi"  
[X Link](https://x.com/zohmbastic/status/2014778798403657954)  2026-01-23T19:14Z 10K followers, [----] engagements


"$DFTX RBC Capital raised the firm's price target on Definium Therapeutics to $36 from $20 and keeps an Outperform rating on the shares. Following the firm's Psychedelics Symposium and discussions with the management the firm has increased expectations for lead drug DT120's long-term sales opportunity the analyst tells investors in a research note. $DFTX https://t.co/aGPUjzLnBf $DFTX https://t.co/aGPUjzLnBf"  
[X Link](https://x.com/zohmbastic/status/2014781859465695702)  2026-01-23T19:26Z 10K followers, [----] engagements


"$LDI intraday block today $LDI https://t.co/OEJ3mOdwrZ $LDI https://t.co/OEJ3mOdwrZ"  
[X Link](https://x.com/zohmbastic/status/2014783558368297348)  2026-01-23T19:33Z 10.1K followers, [----] engagements


"$METC [--] holla $METC March 35c sweep $METC March 35c sweep"  
[X Link](https://x.com/zohmbastic/status/2014784641408942589)  2026-01-23T19:37Z 10.1K followers, [----] engagements


"$METC they started to notice $METC [--] holla $METC [--] holla"  
[X Link](https://x.com/zohmbastic/status/2014785645370077413)  2026-01-23T19:41Z 10.1K followers, [----] engagements


"$GUTS decent eod $GUTS https://t.co/1HjJqgVn9J $GUTS https://t.co/1HjJqgVn9J"  
[X Link](https://x.com/zohmbastic/status/2014800768755286110)  2026-01-23T20:41Z 10K followers, [----] engagements


"$ERAS Erasca Announces Closing of Upsized Public Offering of Common Stock Including Full Exercise of Underwriters Option to Purchase Additional Shares $ERAS nice pricing Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers today announced the pricing of an upsized public offering $ERAS nice pricing Erasca Inc. (Nasdaq: ERAS) a clinical-stage precision oncology company singularly focused on discovering developing and commercializing therapies for"  
[X Link](https://x.com/zohmbastic/status/2014805898175119592)  2026-01-23T21:02Z 10.1K followers, [----] engagements


"$CNEY pump and dump Gaussian distribution vol 🙃"  
[X Link](https://x.com/zohmbastic/status/2014809890284318824)  2026-01-23T21:18Z 10K followers, [----] engagements


"$IOBT Novo Holdings decreased stake to 2.47M 3.3% from 4.98M 7.3% Piper Sandler downgraded to [---] from 3"  
[X Link](https://x.com/zohmbastic/status/2014854674034131229)  2026-01-24T00:16Z 10.1K followers, [---] engagements


"$ERAS Morgan Stanley analyst Sean Laaman raised the firm's price target on Erasca to $10 from $4 and keeps an Equal Weight rating on the shares after the company shared an early clinical look at ERAS-0015 and reported two confirmed partial responses and one unconfirmed PR at [--] mg QD. While these data are "promising" and the firm raised its view of the odds of success as a result it acknowledges "it remains early." $ERAS Erasca Announces Closing of Upsized Public Offering of Common Stock Including Full Exercise of Underwriters Option to Purchase Additional Shares $ERAS Erasca Announces Closing"  
[X Link](https://x.com/zohmbastic/status/2015777128000753708)  2026-01-26T13:21Z 10.1K followers, [----] engagements


"$BBAR nearing [--] $BBAR daily https://t.co/5HohxaVA1o $BBAR daily https://t.co/5HohxaVA1o"  
[X Link](https://x.com/zohmbastic/status/2015811892858470708)  2026-01-26T15:39Z 10.1K followers, [----] engagements


"$AR interesting spread $AR https://t.co/qYcTwi70Qr $AR https://t.co/qYcTwi70Qr"  
[X Link](https://x.com/zohmbastic/status/2015834680184938726)  2026-01-26T17:10Z 10K followers, [----] engagements


"$TEVA nice intra block $TEVA Truist raised the firm's price target on Teva to $36 from $32 and keeps a Buy rating on the shares. The affordable medicines theme remains attractive heading into [----] the analyst tells investors in a research note. $TEVA Truist raised the firm's price target on Teva to $36 from $32 and keeps a Buy rating on the shares. The affordable medicines theme remains attractive heading into [----] the analyst tells investors in a research note"  
[X Link](https://x.com/zohmbastic/status/2015839434843750852)  2026-01-26T17:29Z 10.1K followers, [----] engagements


"$TARA lazy river today $TARA On track to report interim results from approximately [--] six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 [----] Received Breakthrough Therapy and Fast Track designations for TARA-002 in LMs; regulatory update expected in 1H [----] Dosed first patient $TARA On track to report interim results from approximately [--] six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 [----] Received Breakthrough Therapy and Fast Track designations for TARA-002 in LMs; regulatory update expected in 1H [----] Dosed first patient"  
[X Link](https://x.com/zohmbastic/status/2015845626114711919)  2026-01-26T17:53Z 10.1K followers, [----] engagements


"$CRWV Jefferies [---] Jefferies notes Nvidia (NVDA) and CoreWeave (CRWV) deepened their partnership as the former helps the latter push toward over 5GW of AI factories by [----] well above today's 2.9GW. Nvidia's support on land and powered shells should ease execution risk and help scaling Jefferies argues. Furthermore Nvidia will also help take CoreWeave's SUNK/Mission Control software to market creating a high-margin asset-light growth avenue. CoreWeave's stake rises to about 9% from 7% underscoring its conviction in CoreWeave as a strategic partner not just a reseller the firm adds. Jefferies"  
[X Link](https://x.com/zohmbastic/status/2015874041525969187)  2026-01-26T19:46Z 10K followers, [----] engagements


"$CMCSA 200dma $CMCSA As previously reported BofA upgraded Comcast (CMCSA) to Buy from Neutral with a price target of $37 up from $31. The media and cable landscape enters [----] amid significant structural change which sets the stage for "a transformative year" marked by industry $CMCSA As previously reported BofA upgraded Comcast (CMCSA) to Buy from Neutral with a price target of $37 up from $31. The media and cable landscape enters [----] amid significant structural change which sets the stage for "a transformative year" marked by industry"  
[X Link](https://x.com/zohmbastic/status/2015875841033454070)  2026-01-26T19:53Z 10K followers, [----] engagements


"$VSNT = $CMCSA spin off $CMCSA 200dma https://t.co/d96I4IUnPj $CMCSA 200dma https://t.co/d96I4IUnPj"  
[X Link](https://x.com/zohmbastic/status/2015876389841334463)  2026-01-26T19:55Z 10K followers, [----] engagements


"$AB near [--] $AB https://t.co/yCO196Vw4k $AB https://t.co/yCO196Vw4k"  
[X Link](https://x.com/zohmbastic/status/2015878400963977368)  2026-01-26T20:03Z 10K followers, [----] engagements


"$LUNR The National Aeronautics and Space Administration has announced its selection of Intuitive Machines as part of [--] global volunteers chosen to track the Artemis II Mission the company announced. "The company will support the mission using its Space Data Network and ground station infrastructure. Intuitive Machines is among volunteers spanning commercial service providers members of academia and individual amateur radio enthusiasts approved by NASA to track the radio waves transmitted by the Orion spacecraft during its 10-day journey to and around the Moon. The mission's first launch"  
[X Link](https://x.com/zohmbastic/status/2015895032369168646)  2026-01-26T21:10Z 10.1K followers, [----] engagements


"$CAPR Tang 3.4M 6.6% https://www.sec.gov/Archives/edgar/data/1133869/000121465926000831/xslSCHEDULE_13G_X01/primary_doc.xml https://www.sec.gov/Archives/edgar/data/1133869/000121465926000831/xslSCHEDULE_13G_X01/primary_doc.xml"  
[X Link](https://x.com/zohmbastic/status/2015896744215625906)  2026-01-26T21:16Z 10.1K followers, [----] engagements


"$UAA https://www.sec.gov/Archives/edgar/data/915191/000094787126000066/xslF345X05/ownership.xml $UA $UAA a bit conservative PT Citi analyst Paul Lejuez raised the firm's price target on Under Armour to $6.50 from $5 and keeps a Neutral rating on the shares. https://www.sec.gov/Archives/edgar/data/915191/000094787126000066/xslF345X05/ownership.xml $UA $UAA a bit conservative PT Citi analyst Paul Lejuez raised the firm's price target on Under Armour to $6.50 from $5 and keeps a Neutral rating on the shares"  
[X Link](https://x.com/zohmbastic/status/2015935587941851279)  2026-01-26T23:51Z 10K followers, [----] engagements


"$QBTS D-Wave Announces Advancements in Annealing and Gate-Model Quantum Computing Technologies Furthering Companys Unique Dual-Platform Approach"  
[X Link](https://x.com/zohmbastic/status/2016123023997210759)  2026-01-27T12:16Z 10.1K followers, [----] engagements


"$DVN Wells Fargo raised the firm's price target on Devon Energy to $43 from $37 and keeps an Overweight rating on the shares. The oil macro remains pressured with downside-skewed fundamentals as rising OPEC supply and strong non-OPEC growth point to a near-term surplus and continued price pressure Wells notes. Amid a softer macro the firm favors low-reinvestment capital-disciplined frameworks with [----] plans broadly stable across the group. $DVN $CTRA US shale producers Devon Energy and Coterra Energy in merger talks sources say $DVN $CTRA US shale producers Devon Energy and Coterra Energy in"  
[X Link](https://x.com/zohmbastic/status/2016126568767070388)  2026-01-27T12:30Z 10.1K followers, [----] engagements


"$UNH UNITEDHEALTH EXEC SAYS MEDICAL CARE ACTIVITY WILL LIKELY REMAIN AT CURRENT TREND LEVELS THROUGH 2026"  
[X Link](https://x.com/zohmbastic/status/2016141012381376811)  2026-01-27T13:27Z 10K followers, [----] engagements


"$ERAS Guggenheim [--] from [--] Mizuho [--] Mizuho analyst Joseph Catanzaro assumed coverage of Erasca with an Outperform rating and price target of $16 up from $5. The firm says the company's RAS inhibitor portfolio is well positioned to establish proof-of-concept in [----]. ERAS-0015 has opportunity for a wider therapeutic window and a competitive clinical profile the analyst tells investors in a research note. $ERAS Morgan Stanley analyst Sean Laaman raised the firm's price target on Erasca to $10 from $4 and keeps an Equal Weight rating on the shares after the company shared an early clinical look"  
[X Link](https://x.com/zohmbastic/status/2016145931679199459)  2026-01-27T13:47Z 10.1K followers, [----] engagements


"$OMER Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA (narsoplimab-wuug) to its distributors were completed last week with orders from transplant centers beginning that same day. Both adult and pediatric patients with stem cell transplant-associated thrombotic microangiopathy (TA-TMA) are now receiving YARTEMLEA including patients who have recently failed prior off-label C5-inhibitor regimens in both hospital and outpatient settings. YARTEMLEA is the first and only approved therapy for TA-TMA an often-fatal complication of stem cell"  
[X Link](https://x.com/zohmbastic/status/2016149370492649599)  2026-01-27T14:00Z 10K followers, [----] engagements


"$BILI $BILI pcr .103 today $BILI pcr .103 today"  
[X Link](https://x.com/zohmbastic/status/2016174726503162112)  2026-01-27T15:41Z 10.1K followers, [----] engagements


"$TSM may see ATH soon $TSM Jan 310c large sweep $TSM Jan 310c large sweep"  
[X Link](https://x.com/zohmbastic/status/2016180964360093902)  2026-01-27T16:06Z 10K followers, [----] engagements


"$RUN weekly $RUN [--] holla https://t.co/BCRUDRjCFJ $RUN [--] holla https://t.co/BCRUDRjCFJ"  
[X Link](https://x.com/zohmbastic/status/2016183636802863174)  2026-01-27T16:16Z 10.1K followers, [----] engagements


"$eras back above [--] $ERAS Guggenheim [--] from [--] Mizuho [--] Mizuho analyst Joseph Catanzaro assumed coverage of Erasca with an Outperform rating and price target of $16 up from $5. The firm says the company's RAS inhibitor portfolio is well positioned to establish proof-of-concept in [----]. ERAS-0015 $ERAS Guggenheim [--] from [--] Mizuho [--] Mizuho analyst Joseph Catanzaro assumed coverage of Erasca with an Outperform rating and price target of $16 up from $5. The firm says the company's RAS inhibitor portfolio is well positioned to establish proof-of-concept in [----]. ERAS-0015"  
[X Link](https://x.com/zohmbastic/status/2016218676119077224)  2026-01-27T18:36Z 10.1K followers, [----] engagements


"$LUNR $LUNR The National Aeronautics and Space Administration has announced its selection of Intuitive Machines as part of [--] global volunteers chosen to track the Artemis II Mission the company announced. "The company will support the mission using its Space Data Network and ground $LUNR The National Aeronautics and Space Administration has announced its selection of Intuitive Machines as part of [--] global volunteers chosen to track the Artemis II Mission the company announced. "The company will support the mission using its Space Data Network and ground"  
[X Link](https://x.com/zohmbastic/status/2016229145244504403)  2026-01-27T19:17Z 10K followers, [----] engagements


"$MU $MUU $MU Mizuho raised the firm's price target on Micron to $480 from $390 and keeps an Outperform rating on the shares. The firm believes pricing tailwinds in the legacy DRAM and NAND markets will drive better sales and margins in [----] for the memory group. Mizuho expects no new NAND $MU Mizuho raised the firm's price target on Micron to $480 from $390 and keeps an Outperform rating on the shares. The firm believes pricing tailwinds in the legacy DRAM and NAND markets will drive better sales and margins in [----] for the memory group. Mizuho expects no new NAND"  
[X Link](https://x.com/zohmbastic/status/2016246729255837801)  2026-01-27T20:27Z 10.1K followers, [----] engagements


"$ESPR 3.5s tap in PH $ESPR https://t.co/ifc6JvMzkn $ESPR https://t.co/ifc6JvMzkn"  
[X Link](https://x.com/zohmbastic/status/2016246943807103458)  2026-01-27T20:28Z 10K followers, [----] engagements


"$BIOA intra high $BIOA Piper Sandler initiated coverage of BioAge Labs with an Overweight rating and $73 price target. The company's BGE-102 is an oral QD CNS-penetrant NLRP3 inhibitor small-molecule with "strong" Phase [--] data in obese patients the analyst tells investors in a research note. $BIOA Piper Sandler initiated coverage of BioAge Labs with an Overweight rating and $73 price target. The company's BGE-102 is an oral QD CNS-penetrant NLRP3 inhibitor small-molecule with "strong" Phase [--] data in obese patients the analyst tells investors in a research note"  
[X Link](https://x.com/zohmbastic/status/2016249467029045456)  2026-01-27T20:38Z 10.1K followers, [----] engagements


"$ERAS [----] high $eras back above [--] https://t.co/hR2Pg27cWt $eras back above [--] https://t.co/hR2Pg27cWt"  
[X Link](https://x.com/zohmbastic/status/2016254550970159560)  2026-01-27T20:58Z 10.1K followers, [----] engagements


"$TXN TEXAS INSTRUMENTS CEO SAYS DATA CENTER REVENUE IN [----] WAS $1.5 BILLION UP 64% YEAR-ON-YEAR"  
[X Link](https://x.com/zohmbastic/status/2016266934707204566)  2026-01-27T21:47Z 10K followers, [----] engagements


"$ATOM Atomera Incorporated (NASDAQ:ATOM) a semiconductor materials and technology licensing company today announced that its concept paper on Gallium Nitride on Silicon (GaN-on-Si) technologies has been accepted to move to the proposal stage as part of a PowerAmerica Institute Initiated Proposal (IIP) to advance wide-bandgap (WBG) power semiconductor technology. The paper which proposes a collaboration with other industry and scientific partners details Atomeras Mears Silicon Technology (MST) improvements in GaN material quality as compared with GaN films formed on standard silicon. Approval"  
[X Link](https://x.com/zohmbastic/status/2016271575801041149)  2026-01-27T22:06Z 10K followers, [----] engagements


"$PDYN Palladyne AI Awarded U.S. Air Force Contract to Advance Swarming Capabilities for Integrated Cross-Domain Operations $PDYN Palladyne AI Corp. Signals Operating Inflection With Increase to Full Year [----] Revenue Guidance to $24 - $27 Million Represents 336% to 440% Year-Over-Year Increase Driven By Late [----] Acquisitions Contracted demand and recent acquisitions support transition into higher $PDYN Palladyne AI Corp. Signals Operating Inflection With Increase to Full Year [----] Revenue Guidance to $24 - $27 Million Represents 336% to 440% Year-Over-Year Increase Driven By Late 2025"  
[X Link](https://x.com/zohmbastic/status/2016481547461730765)  2026-01-28T12:00Z 10.1K followers, 18K engagements


"$RDW Roth Capital raised the firm's price target on Redwire to $20 from $15 and keeps a Buy rating on the shares. The company has announced it has secured part of a defense contract award relating to the government's Golden Dome Program and while no specific awards have been committed to yet the firm is encouraged by Redwire's inclusion stating that its portfolio position as a key space infrastructure vendor can serve it well as this major defense program evolves the analyst tells investors in a research note. $RDW https://t.co/6bxud0hWWn $RDW https://t.co/6bxud0hWWn"  
[X Link](https://x.com/zohmbastic/status/2016486398203748782)  2026-01-28T12:19Z 10K followers, [----] engagements


"$ZETA Goldman Sachs raised the firm's price target on Zeta Global to $26 from $23 and keeps a Neutral rating on the shares. Software M&A activity is expected to accelerate in [----] driven by compressed public valuations and the structural advantages of software businesses including distribution domain expertise data moats and brand equity the analyst tells investors in a research note This could enable value creation through cross-portfolio synergies acquisitions of top private-market technologies and leveraging SaaS incumbents at more attractive multiples the firm says. $ZETA Morgan Stanley"  
[X Link](https://x.com/zohmbastic/status/2016498676118491488)  2026-01-28T13:08Z 10.1K followers, [----] engagements


"$ONDS Ondas' American Robotics Optimus Drone Approved for Rapid Federal Procurement via DCMA Blue UAS Cleared List $ONDS https://t.co/91KV5unDiv $ONDS https://t.co/91KV5unDiv"  
[X Link](https://x.com/zohmbastic/status/2016504263111778589)  2026-01-28T13:30Z 10.1K followers, [----] engagements


"$INTC 50c trimmed $INTC took a few Feb 50c starter size $INTC took a few Feb 50c starter size"  
[X Link](https://x.com/zohmbastic/status/2016522480245002358)  2026-01-28T14:43Z 10K followers, [----] engagements


"$B intact $B https://t.co/M7EWRnqUwp $B https://t.co/M7EWRnqUwp"  
[X Link](https://x.com/zohmbastic/status/2016522750202925152)  2026-01-28T14:44Z 10.1K followers, [----] engagements


"$WYFI $WYFI https://t.co/mfEygV9qZ4 $WYFI https://t.co/mfEygV9qZ4"  
[X Link](https://x.com/zohmbastic/status/2016526086117417279)  2026-01-28T14:57Z 10.1K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing